W. Jeffrey Fessel - Concepedia

Author

W. Jeffrey Fessel

Also Known As

D L Bruce, N Brautbar, W Fessel, W J Fessel, W Jeffrey Fessel, W. J. FESSEL, W. J. Fessel, W. Jeffrey Fessel, W. Jeffrey Fessel, William J Fessel

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Stanford University Kaiser Permanente Kaiser Permanente San Francisco Medical Center Harvard University University of Cologne

About

W. Jeffrey Fessel is an author at Stanford University specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	913
2	Immunology	6	6	361
3	Epidemiology	5	5	749
4	Public Health	3	3	491
5	Social Sciences	1	1	31

W. Jeffrey Fessel

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Systemic Lupus Erythematosus in the Community W. Jeffrey Fessel Archives of Internal Medicine Glomerular DiseaseDermatologyClinical EpidemiologyPublic HealthSkewed Series	1974	410
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study John Gregson, Michele W. Tang, Nicaise Ndembi, The Lancet Infectious Diseases	2016	274
Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments Thomas D. Wu, Celia A. Schiffer, Matthew J. Gonzales, Journal of Virology	2003	238
HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance Soo‐Yon Rhee, Jonathan Taylor, W. Jeffrey Fessel, Antimicrobial Agents and Chemotherapy Primary ImmunodeficiencyHiv-1 Protease MutationsDisease SusceptibilityIncreased SusceptibilityMedicine	2010	226
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Richard E. Chaisson, Philip Keiser, Mark A. Pierce, AIDS	1997	148
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing George Melikian, Soo‐Yon Rhee, Vici Varghese, Journal of Antimicrobial Chemotherapy	2013	133
Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy Rami Kantor, Robert W. Shafer, Stephen Follansbee, AIDS	2004	132
HIV‐1 Protease and Reverse‐Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug‐Resistance Surveillance Soo‐Yon Rhee, W. Jeffrey Fessel, Andrew Zolopa, The Journal of Infectious Diseases	2005	123
Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors Matthew J. Gonzales, Thomas D. Wu, Jonathan Taylor, AIDS	2003	108
Minority Variants Associated with Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors Vici Varghese, Rajin Shahriar, Soo‐Yon Rhee, JAIDS Journal of Acquired Immune Deficiency Syndromes	2009	96

Page 1